|
Market Closed -
NYSE
16:00:02 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 12.54 USD | +0.08% |
|
+2.03% | -21.77% |
Company Valuation: Core Laboratories Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,033 | 939.9 | 825.1 | 812.7 | 746.4 | 574.9 | - |
| Change | - | -8.98% | -12.21% | -1.51% | -8.16% | -22.97% | - |
| Enterprise Value (EV) | 1,204 | 1,097 | 973.2 | 919.7 | 746.4 | 574.9 | 574.9 |
| Change | - | -8.87% | -11.28% | -5.5% | -18.84% | -22.97% | 0% |
| P/E | 53.1x | 48.3x | 20.5x | 26.2x | 23.6x | 29.1x | 16.4x |
| PBR | 6.47x | 5.02x | - | - | - | - | - |
| PEG | - | - | 0x | -1.1x | 7.79x | -0.8x | 0.2x |
| Capitalization / Revenue | 2.2x | 1.92x | 1.62x | 1.55x | 1.42x | 1.13x | 1.07x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.13x | 1.07x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 10.4x | 8.38x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 14.4x | 10.2x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 25.7x | 11.8x |
| FCF Yield | 2.23% | 1.57% | 1.72% | 5.34% | 3.48% | 3.9% | 8.45% |
| Dividend per Share 2 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Rate of return | 0.18% | 0.2% | 0.23% | 0.23% | 0.25% | 0.32% | 0.32% |
| EPS 2 | 0.42 | 0.42 | 0.86 | 0.66 | 0.68 | 0.43 | 0.765 |
| Distribution rate | 9.52% | 9.52% | 4.65% | 6.06% | 5.88% | 9.3% | 5.23% |
| Net sales 1 | 470.3 | 489.7 | 509.8 | 523.8 | 526.5 | 510.2 | 535.2 |
| EBITDA 1 | 70.81 | 61.98 | 76.96 | 80.2 | 73.34 | 55.38 | 68.63 |
| EBIT 1 | 52.29 | 44.82 | 61.18 | 65.25 | 58.7 | 39.94 | 56.25 |
| Net income 1 | 19.73 | 19.45 | 40.94 | 31.4 | 31.8 | 19.87 | 35.85 |
| Net Debt | 170.9 | 157 | 148 | 107 | - | - | - |
| Reference price 2 | 22.31 | 20.27 | 17.66 | 17.31 | 16.03 | 12.53 | 12.53 |
| Nbr of stocks (in thousands) | 46,290 | 46,371 | 46,724 | 46,950 | 46,563 | 45,885 | - |
| Announcement Date | 2/2/22 | 2/1/23 | 1/31/24 | 1/29/25 | 2/4/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 29.14x | - | - | 0.32% | 575M | ||
| 24.75x | 2.79x | 12.53x | 3.47% | 22.49B | ||
| 20.59x | 3.04x | 12.45x | 1.31% | 3.68B | ||
| 12.75x | - | - | 2.41% | 2.1B | ||
| -33.38x | 1.47x | 9.52x | -.--% | 2.04B | ||
| 22.26x | - | - | 2.22% | 1.59B | ||
| 38.93x | - | - | - | 1.35B | ||
| Average | 16.43x | 2.43x | 11.50x | 1.62% | 4.83B | |
| Weighted average by Cap. | 20.57x | 2.73x | 12.30x | 2.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CLB Stock
- Valuation Core Laboratories Inc.
Select your edition
All financial news and data tailored to specific country editions
















